Physician profile
Christopher James
NPI 1932603222
$1,705.21
in general payments reported to CMS, 2019-2025
14 companies · $781 in 2025
The $781 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $279 · 2021: $52.35 · 2022: $229 · 2023: $327 · 2024: $36.29 · 2025: $781.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,144.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $602.64 | 2019-2025 | Lithovue, Spaceoar Vue System - 10ml, Lithoclast |
| Teleflex LLC | $345.71 | 2025 | Barrigel, Urolift |
| Cook Medical LLC | $213.57 | 2023-2025 | Ncircle, Fiber Dust |
| Depuy Synthes Sales INC. | $130.32 | 2023 | Na |
| Mml US, INC. | $75.49 | 2025 | Reactiv8 |
| Procept Biorobotics Corporation | $62.90 | 2025 | |
| Calyxo, INC. | $60.12 | 2025 | Cvac Aspiration System |
| Allergan, INC. | $52.35 | 2021 | |
| Medical Device Business Services, INC. | $36.79 | 2022-2023 | |
| Janssen Biotech, INC. | $36.29 | 2024 | Erleada |
| Stryker Corporation | $27.88 | 2019 | |
| Emd Serono, INC. | $24.69 | 2022 | |
| Axonics, INC. | $22.66 | 2023 | Axonics, Bulkamid |
| Agiliti Surgical, INC. | $13.80 | 2025 | Koelis Trinity Mri/US Fusion |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher James listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.